Sangwoo Lee

Director at PDC*line Pharma

Sangwoo is a head of Korea Investment Partners US office since 2016, before his career in Venture Capital, Sangwoo has 18 years of industrial experiences in diverse area and companies in IT including Samsung Electronics, Dasan networks, and successful venture startups of Neomtel and Polidigm. His diverse area of experience covers from IT engineering skills like sw design/development, algorithm design/implementation, network protocol to service planning and company management. In startups of Neomtel and Polidigm, Sangwoo led the core engineering development as CTO. Neomtel introduced a new service concept of mobile image compression and transmission at 2000 and its graphice technology became a de-facto standard in Korea at early 2000s. The technology was adapted by Qualcomm later and the company went IPO at 2007.

Sangwoo is responsible for global expansion of Korea Investment Partners and actively exploring cross-border investments. Current investment portfolio of Sangwoo is diverse from BIO-Healthcare companies like Elastagen, Auris Surgical Robotics, KAHR to IT/Fintech companies such as SoFi, Le Tote.

Sangwoo is currently managing over 10 investment port folios and active in more than 5 board positions.

Sangwoo received his B.S. and M.S. in Control and Instrumentation Engineering from Seoul National University .

He is a fluent English speaker.